Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer

Robin M Meyers1, Jordan G Bryan1, James M McFarland1

  • 1Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

Nature Genetics
|October 31, 2017
PubMed

Insights

We developed CERES, a computational method to improve CRISPR-Cas9 screens for cancer gene essentiality. This tool reduces false positives, enabling better identification of cancer-specific vulnerabilities.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • CRISPR-Cas9 gene editing enables genome-scale screens to identify essential genes in cancer cells.
  • Cas9-mediated DNA cleavage can cause gene-independent antiproliferative effects, leading to false positives in essentiality screens, especially in copy number-amplified regions.

Purpose of the Study:

  • To develop a computational method, CERES, to accurately estimate gene dependency from CRISPR-Cas9 screens by accounting for copy number effects.
  • To create a comprehensive cancer dependency map using genome-scale CRISPR-Cas9 essentiality screens.

Main Methods:

  • Development of the CERES computational method to correct for copy number-specific effects in CRISPR-Cas9 essentiality screens.
  • Performance of genome-scale CRISPR-Cas9 essentiality screens across 342 cancer cell lines.
  • Application of CERES to analyze both new and existing CRISPR-Cas9 screen datasets.

Main Results:

  • CERES effectively reduced false-positive results in CRISPR-Cas9 essentiality screens.
  • The method accurately estimated single-guide RNA (sgRNA) activity across different sgRNA libraries and datasets.
  • The corrected dataset facilitated the identification of cancer-type-specific vulnerabilities.

Conclusions:

  • CERES provides a more accurate assessment of gene essentiality in cancer cells by mitigating Cas9-induced artifacts.
  • The cancer dependency map generated using CERES offers a valuable resource for discovering novel cancer-specific therapeutic targets.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.1K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.1K
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
64.1K